Full Year 2022 Hua Medicine Earnings Call Transcript
Before we kick up the session, I would like to highlight that this call is strictly for clients of Goldman Sachs and Hua Medicine only. And this conversation is not intended for the media and is off the record.
Participants will be removed from the call if they cannot be properly identified and this webcast is not for the purpose sharing or receiving nonpublic otherwise confidential information. And attendees or public and market participants who may not receive or request nonpublic, otherwise confidential information about issuers or securities or about the markets for securities.
So during today's call, Hua Medicine management team, including the Co-Founder and CEO, Dr. Li Chen; and the EVP and CFO, Mr. George Lin. So company is going to give us a briefing on the results, particularly Hua Medicine's, this is its first year into commercialization. So there has been a lot of updates here and also in terms of R&D progress. And then we're going to open the line for Q&A. If you have any questions, you can
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |